Physician profile
Allison Landes
NPI 1336330190
$3,509.63
in general payments reported to CMS, 2019-2025
17 companies · $359 in 2025
The $359 reported for 2025 was less than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $50.93 · 2020: $57.32 · 2021: $122 · 2022: $1,971 · 2023: $241 · 2024: $709 · 2025: $359.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,309.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,309.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biotissue Holdings INC. | $1,815.98 | 2022 | |
| Alcon Vision LLC | $656.41 | 2021-2025 | Clareon, Acrysof Iq Panoptix Uv Iol, Acrysof Iq Vivity |
| Revance Therapeutics, INC. | $331.63 | 2024-2025 | Daxxify |
| Novartis Pharmaceuticals Corporation | $146.74 | 2020-2023 | |
| Tarsus Pharmaceuticals, INC. | $125.33 | 2024-2025 | Xdemvy |
| Bausch & Lomb Americas INC. | $90.39 | 2023-2025 | Miebo, Xiidra |
| Ivantis, INC | $79.01 | 2019-2021 | |
| Dompe US, INC. | $58.92 | 2024 | Oxervate |
| Johnson & Johnson Surgical Vision, INC. | $41.12 | 2024 | Tecnis Iol |
| Abbvie INC. | $39.52 | 2022-2025 | |
| Allergan, INC. | $33.87 | 2019-2021 | |
| Amgen INC. | $21.16 | 2025 | Tepezza |
| Sight Sciences, INC. | $20.79 | 2022 | |
| Tearlab Corp | $17.00 | 2022 | |
| Kala Pharmaceuticals, INC. | $15.43 | 2020 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shire North American Group INC | $14.57 | 2019 | |
| New World Medical,INC. | $1.76 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Allison Landes listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.